Gastric Bypass Surgery Restored the GLP-1 and PYY Peptide Response to Exercise in Women With Severe Obesity
After gastric bypass surgery, women with severe obesity showed dramatically improved GLP-1 and PYY peptide responses to post-meal exercise, with GLP-1 AUC increasing 6-fold and PYY AUC increasing 22-fold compared to pre-surgery.
Quick Facts
What This Study Found
Thirteen women with severe obesity (BMI 47.6 ± 5.6) underwent exercise sessions before and 3 months after Roux-en-Y gastric bypass:
Pre-surgery: No significant GLP-1 or PYY changes with post-meal exercise (all P>0.05)
Post-surgery:
- GLP-1 increased immediately (P=0.0180) and 30 min after exercise (P=0.0380); AUC rose from 2.3 to 14.5 pg/mL×min (P=0.0075) — a 6.3-fold increase
- PYY increased immediately (P=0.0020) and 30 min after exercise (P=0.0360); AUC rose from 9.9 to 224.2 pg/mL×min (P=0.0004) — a 22.6-fold increase
- Insulin AUC decreased (60.7 to 26.3 µU/mL×min; P=0.0457), indicating improved insulin sensitivity
- PP and GIP AUC decreased post-surgery
- Ghrelin levels and inflammatory markers were unchanged
Key Numbers
How They Did This
Thirteen women (age 37±7, BMI 47.6±5.6) completed an exercise session consisting of resistance training plus aerobic exercise in a postprandial state, both before and 3 months after Roux-en-Y gastric bypass surgery. Blood samples were collected at baseline, immediately after, and 30 minutes after exercise. Glucose, insulin, GLP-1, PYY, PP, GIP, ghrelin, and inflammatory markers were measured. Within-subject comparisons used pre- vs post-surgery exercise responses. AUC (area under the curve) was calculated for each hormone.
Why This Research Matters
This study reveals a key mechanism through which gastric bypass produces metabolic benefits: it restores the gut's ability to release appetite-suppressing and glucose-regulating peptides in response to exercise. The dramatic increases in GLP-1 and PYY after surgery help explain why patients eat less, have better blood sugar control, and lose weight. It also suggests that exercise and surgery work synergistically — combining both may produce greater metabolic benefits than either alone.
The Bigger Picture
The explosion of interest in GLP-1 drugs (semaglutide, tirzepatide) has renewed focus on why bariatric surgery is so effective — and a key answer is that surgery dramatically amplifies the body's own GLP-1 and PYY production. This study adds the exercise dimension, showing that the hormonal benefits of surgery are further enhanced when combined with physical activity. Understanding these natural peptide hormone responses may guide the development of combination therapies that mimic the most beneficial aspects of both surgery and pharmacotherapy.
What This Study Doesn't Tell Us
Very small sample size (13 women) limits statistical power and generalizability. Only women were studied, so results may not apply to men. The 3-month post-surgery timepoint captures early changes — longer-term adaptations may differ. There was no non-surgical control group, so it's impossible to determine how much of the hormonal change is due to surgery versus weight loss itself. The exercise protocol combined resistance and aerobic training, making it difficult to determine which type of exercise drives the hormonal response.
Questions This Raises
- ?Would the same exercise-induced GLP-1 and PYY surge occur in patients who lose equivalent weight through GLP-1 drugs without surgery?
- ?Is the amplified peptide hormone response to exercise a key factor in maintaining weight loss long-term after bariatric surgery?
- ?Could timing exercise after meals be a specific strategy to maximize gut hormone responses in post-surgery patients?
Trust & Context
- Key Stat:
- 22-fold PYY increase after surgery PYY AUC in response to post-meal exercise rose from 9.9 to 224.2 pg/mL×min three months after gastric bypass (P=0.0004)
- Evidence Grade:
- This is a small pre-post observational study with 13 participants and no control group. The within-subject design reduces variability, and the highly significant P-values for GLP-1 and PYY changes are convincing despite the small sample. However, the lack of a control group limits causal conclusions about surgery specifically versus weight loss generally.
- Study Age:
- Published in 2025, this study is very current and addresses the timely intersection of bariatric surgery, exercise physiology, and gut hormone biology in the era of GLP-1 pharmacotherapy.
- Original Title:
- Roux-en-Y Gastric Bypass Improves Insulin Response and Secretion of GLP-1 and PYY in Response to Postprandial Acute Exercise.
- Published In:
- Obesity surgery, 35(12), 4989-4999 (2025)
- Authors:
- Gil, Saulo, Murai, Igor Hisashi, Dantas, Wagner S, Merege-Filho, Carlos Alberto Abujabra, Leitão, Alice Erwig, Nicoletti, Carolina Ferreira, Lima, Alisson Padilha de, Benatti, Fabiana, Cleva, Roberto de, Santo, Marco Aurélio, Kirwan, John P, Gualano, Bruno, Roschel, Hamilton
- Database ID:
- RPEP-11101
Evidence Hierarchy
Frequently Asked Questions
Why does gastric bypass change how the gut responds to exercise?
Gastric bypass surgery reroutes food to bypass most of the stomach and the first part of the small intestine. This means partially digested food reaches the lower intestine much faster, where GLP-1 and PYY-producing cells are concentrated. Before surgery, severe obesity blunts the normal hormone response to eating and exercise. After surgery, the combination of gut rerouting and weight loss restores — and actually amplifies — these hormone responses, especially when exercise stimulates digestion.
Could exercising after meals help people who haven't had surgery?
Post-meal exercise does stimulate some GLP-1 and PYY release in people without surgery, but the effect is much smaller than what this study found in post-surgery patients. The dramatic hormone surges seen here are largely due to the anatomical changes of gastric bypass, which deliver food directly to hormone-producing cells. For non-surgical patients, post-meal walking or light exercise can still help with blood sugar control, but the gut hormone boost will be more modest.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11101APA
Gil, Saulo; Murai, Igor Hisashi; Dantas, Wagner S; Merege-Filho, Carlos Alberto Abujabra; Leitão, Alice Erwig; Nicoletti, Carolina Ferreira; Lima, Alisson Padilha de; Benatti, Fabiana; Cleva, Roberto de; Santo, Marco Aurélio; Kirwan, John P; Gualano, Bruno; Roschel, Hamilton. (2025). Roux-en-Y Gastric Bypass Improves Insulin Response and Secretion of GLP-1 and PYY in Response to Postprandial Acute Exercise.. Obesity surgery, 35(12), 4989-4999. https://doi.org/10.1007/s11695-025-08327-0
MLA
Gil, Saulo, et al. "Roux-en-Y Gastric Bypass Improves Insulin Response and Secretion of GLP-1 and PYY in Response to Postprandial Acute Exercise.." Obesity surgery, 2025. https://doi.org/10.1007/s11695-025-08327-0
RethinkPeptides
RethinkPeptides Research Database. "Roux-en-Y Gastric Bypass Improves Insulin Response and Secre..." RPEP-11101. Retrieved from https://rethinkpeptides.com/research/gil-2025-rouxeny-gastric-bypass-improves
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.